Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FRACTYL HEALTH, INC.GUTS · Entity 6700 | Director | June 10, 2026 | June 11, 2026 |
| Invivyd, Inc.IVVD · Entity 721 | Director | August 31, 2026 | September 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FRACTYL HEALTH, INC.
Report date June 10, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,000 |
Reported balance
After 2026-06-10 transaction · row 1
1 source rowRow 1 · 2026-06-10 · Purchase · Acquired 35,000 · Balance 35,000 F1: Open market purchase. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.73 · Expires 2036-06-09 | Direct | 22,500 |
Reported balance
After 2026-06-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-10 · Grant · Acquired 22,500 · Balance 22,500 F2: The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Open market purchase.
F2: The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date.
Invivyd, Inc.
Report date August 31, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.95 · Expires 2036-08-30 | Direct | 100,000 |
Reported balance
After 2026-08-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-31 · Grant · Acquired 100,000 · Balance 100,000 F1: This option was granted on August 31, 2026 and vests over a three-year period, with one-third of the shares subject to the grant vesting on the first anniversary of the grant date and 1/36th of the total shares subject to the grant vesting in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: This option was granted on August 31, 2026 and vests over a three-year period, with one-third of the shares subject to the grant vesting on the first anniversary of the grant date and 1/36th of the total shares subject to the grant vesting in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2026 Filed Sep 2, 2026 20:40 UTC | Invivyd, Inc. IVVD · Entity 721 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001193125-26-380337 · ownership.xml · derivative · entry 1 Sheffield Ian · CIK 0001594410 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2036-08-30 F1 · derivative.exercise_date: This option was granted on August 31, 2026 and vests over a three-year period, with one-third of the shares subject to the grant vesting on the first anniversary of the grant date and 1/36th of the total shares subject to the grant vesting in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 21:00 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | GrantStock Option · Derivative | 22,500 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001193125-26-267838 · ownership.xml · derivative · entry 2 Sheffield Ian · CIK 0001594410 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2036-06-09 F2 · derivative.exercise_date: The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date. Read SEC document |
| June 10, 2026 Filed Jun 11, 2026 21:00 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | PurchaseCommon Stock | 35,000 | $0.73 | $25,529.00 |
DisclosureSEC source: 0001193125-26-267838 · ownership.xml · nonDerivative · entry 1 Sheffield Ian · CIK 0001594410 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 F1 · kind: Open market purchase. Read SEC document |
| September 02, 2025 Filed Sep 5, 2025 00:07 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | GrantStock Option · Derivative | 45,000 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0000950170-25-113112 · ownership.xml · derivative · entry 1 Sheffield Ian · CIK 0001594410 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2035-09-01 F1 · derivative.exercise_date: The stock option was awarded for the Reporting Person's appointment on the Issuer's board of directors pursuant to the Issuer's non-employee compensation policy. The stock option vests in three annual installments beginning on the first anniversary of the grant in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.